Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GuShenPinChuan (固肾平喘) is a traditional Chinese medicine (TCM) formula used primarily for the management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). The name translates to "Tonify Kidney and Calm Wheezing," reflecting its TCM principle of strengthening kidney function and relieving symptoms like wheezing or shortness of breath. The formulation typically contains a combination of herbal ingredients, which may include rehmannia root, epimedium, morinda root, psoralea fruit, schisandra fruit, among others. These herbs are believed in TCM theory to nourish kidney yang/qi and support lung function. There is limited high-quality clinical evidence from Western medicine regarding its efficacy or safety profile; most available data come from small studies or traditional use reports. Mechanistically in TCM terms, it is not described by molecular targets but rather by holistic effects on organ systems.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GuShenPinChuan.